Singapore markets close in 6 hours 36 minutes
  • Straits Times Index

    3,179.46
    -3.44 (-0.11%)
     
  • Nikkei

    27,647.74
    +63.66 (+0.23%)
     
  • Hang Seng

    26,517.75
    +91.20 (+0.35%)
     
  • FTSE 100

    7,123.86
    +18.14 (+0.26%)
     
  • BTC-USD

    39,799.30
    +1,357.82 (+3.53%)
     
  • CMC Crypto 200

    981.48
    +54.71 (+5.90%)
     
  • S&P 500

    4,402.66
    -20.49 (-0.46%)
     
  • Dow

    34,792.67
    -323.73 (-0.92%)
     
  • Nasdaq

    14,780.53
    +19.24 (+0.13%)
     
  • Gold

    1,812.10
    -2.40 (-0.13%)
     
  • Crude Oil

    68.39
    +0.24 (+0.35%)
     
  • 10-Yr Bond

    1.1840
    +0.0080 (+0.68%)
     
  • FTSE Bursa Malaysia

    1,496.05
    +4.72 (+0.32%)
     
  • Jakarta Composite Index

    6,187.45
    +28.42 (+0.46%)
     
  • PSE Index

    6,584.45
    -0.76 (-0.01%)
     

Biotech Ingredients Market Size to Reach $75.3 Billion by 2028 | CAGR: 4.8%: AMR

·3-min read

Shift in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech ingredients market. By product, the monoclonal antibodies segment held the major share in 2020. By region, on the other hand, the market across Asia-Pacific would garner the fastest CAGR by 2028.

Portland, OR, June 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global biotech ingredients market was pegged at $51.3 billion in 2020 and is estimated to hit $75.3 billion by 2028, registering a CAGR of 4.8% from 2021 to 2028. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.

Shift in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech ingredients market. On the other hand, limited availability of raw materials restrains the growth to some extent. However, favorable government policies and technological advancements in bio-engineering are expected to create lucrative opportunities in the industry.

Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/11710

COVID-19 scenario-

  • The outbreak of the pandemic has given way to either closure or suspension of production activities in most industrial units across the globe, which has impacted the market negatively.

  • Nevertheless, initiation of mass vaccination in most countries is projected to mend the global situation and market is expected to get back on track soon.

The global biotech ingredients market is analyzed across type, product, expression systems, and region. Based on type, the active pharmaceutical ingredients (APIs) segment accounted for nearly three-fifths of the total market share in 2020 and is expected to rule the roost by the end of 2028. The biosimilars segment, on the other hand, would exhibit the fastest CAGR of 5.0% during the forecast period.

Based on product, the monoclonal antibodies segment contributed to more than one-fifth of the total market revenue in 2020 and is expected to dominate by 2028. However, the hormones and growth factors segment would cite the fastest CAGR of 5.5% during from 2021 to 2028.

Get Detailed COVID-19 Impact Analysis on the Biotech Ingredients Market: https://www.alliedmarketresearch.com/request-for-customization/11710?reqfor=covid

Based on region, Europe held the major share in 2020, garnering nearly two-fifths of the global market. At the same time, the market across Asia-Pacific would register the fastest CAGR of 5.2% from 2021 to 2028. The other regions studied in the report include LAMEA and North America

The key market players analyzed in the global biotech ingredients market report include Pfizer Inc., Novartis International AG, AstraZeneca plc., Teva Pharmaceutical Industries Ltd., Mylan, Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, and Merck & Co. These market players have incorporated several strategies including partnership, expansion, collaboration, joint ventures, and others to brace their stand in the industry.

Interested in Procuring This Report? Visit Here: https://www.alliedmarketresearch.com/biotech-ingredients-market/purchase-options

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: 1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on: LinkedIn Twitter


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting